Literature DB >> 4263649

Studies in porphyria. I. A defect in the reductive transformation of natural steroid hormones in the hereditary liver disease, acute intermittent porphyria.

A Kappas, H L Bradlow, P N Gillette, T F Gallagher.   

Abstract

A variety of 5beta steroid metabolites derived from hormones natural to man are potent inducers experimentally of delta-aminolevulinate synthetase, the rate-limiting enzyme in porphyrin-heme formation. This mitochondrial enzyme is found at high levels of activity in the livers of patients with the genetic disease, acute intermittent porphyria (AIP). In this study the metabolism of (14)C-labeled testosterone was examined in AIP patients to determine whether there was a disproportionate conversion of the hormone to its 5beta, compared to its 5alpha metabolite. The results indicate that AIP subjects do generate a substantially greater than normal fraction of 5beta metabolite from this steroid; the excessive degree of ring A reduction of testosterone taking place via the 5beta pathway in the porphyric patients averages 350% greater than in the nonporphyric subjects. In one asymptomatic AIP patient the disproportionate generation of 5beta metabolite from the hormone reached a level 10 times the normal mean. Studies with a second (14)C-labeled hormone, dehydroisoandrosterone, whose metabolism in man resembles that of testosterone, confirmed the derangement in reductive transformation of steroids found in the individuals carrying the genetic lesion of AIP. These findings define a new endocrine abnormality in AIP patients and raise the possibility that endogenously derived 5beta steroids may contribute by an induction mechanism to the increased levels of hepatic delta-aminolevulinate synthetase activity found in AIP patients.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4263649      PMCID: PMC2139305          DOI: 10.1084/jem.136.5.1043

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  A SUGGESTED CONTROL GENE MECHANISM FOR THE EXCESSIVE PRODUCTION OF TYPES I AND 3 PORPHYRINS IN CONGENITAL ERYTHROPOIETIC PORPHYRIA.

Authors:  C J WATSON; W RUNGE; L TADDEINI; I BOSSENMAIER; R CARDINAL
Journal:  Proc Natl Acad Sci U S A       Date:  1964-08       Impact factor: 11.205

2.  ACUTE INTERMITTENT PORPHYRIA: THE FIRST "OVERPRODUCTION DISEASE" LOCALIZED TO A SPECIFIC ENZYME.

Authors:  D P TSCHUDY; M G PERLROTH; H S MARVER; A COLLINS; G HUNTER; M RECHCIGL
Journal:  Proc Natl Acad Sci U S A       Date:  1965-04       Impact factor: 11.205

3.  Excessive urinary excretion of certain porphyrinogenic steroids in human acute intermittent porphyria.

Authors:  A Goldberg; M R Moore; A D Beattie; P E Hall; J McCallum; J K Grant
Journal:  Lancet       Date:  1969-01-18       Impact factor: 79.321

Review 4.  Acute intermittent porphyria. A clinical and biochemical study of 46 patients.

Authors:  J A Stein; D P Tschudy
Journal:  Medicine (Baltimore)       Date:  1970-01       Impact factor: 1.889

Review 5.  Biochemical and clinical aspects of the porphyrias.

Authors:  R D Levere; A Kappas
Journal:  Adv Clin Chem       Date:  1968       Impact factor: 5.394

Review 6.  Disturbances of liver porphyrin metabolism caused by drugs.

Authors:  F de Matteis
Journal:  Pharmacol Rev       Date:  1967-12       Impact factor: 25.468

7.  The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals.

Authors:  K Miyagi; R Cardinal; I Bossenmaier; C J Watson
Journal:  J Lab Clin Med       Date:  1971-11

8.  Steroid adsorption with polyethylene tubinh.g.

Authors:  J Levin; E H Friedrich; J Lobotsky
Journal:  J Clin Endocrinol Metab       Date:  1965-11       Impact factor: 5.958

9.  Activity of amino-laevulinic acid synthetase in normal and porphyric human livers.

Authors:  K Nakao; O Wada; T Kitamura; K Uono; G Urata
Journal:  Nature       Date:  1966-05-21       Impact factor: 49.962

10.  Steroid induction of porphyrin synthesis in liver cell culture. I. Structural basis and possible physiological role in the control of heme formation.

Authors:  S Granick; A Kappas
Journal:  J Biol Chem       Date:  1967-10-25       Impact factor: 5.157

View more
  8 in total

1.  Studies in porphyria. VII. Induction of uroporphyrinogen-I synthase and expression of the gene defect of acute intermittent porphyria in mitogen-stimulated human lymphocytes.

Authors:  S Sassa; G L Zalar; A Kappas
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

2.  A microassay for uroporphyrinogen I synthase, one of three abnormal enzyme activities in acute intermittent porphyria, and its application to the study of the genetics of this disease.

Authors:  S Sassa; S Granick; D R Bickers; H L Bradlow; A Kappas
Journal:  Proc Natl Acad Sci U S A       Date:  1974-03       Impact factor: 11.205

3.  Induction of a deficiency of steroid delta 4-5 alpha-reductase activity in liver by a porphyrinogenic drug.

Authors:  A Kappas; H L Bradlow; D R Bickers; A P Alvares
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

4.  Nutrition-endocrine interactions: induction of reciprocal changes in the delta 4-5 alpha-reduction of testosterone and the cytochrome P-450-dependent oxidation of estradiol by dietary macronutrients in man.

Authors:  A Kappas; K E Anderson; A H Conney; E J Pantuck; J Fishman; H L Bradlow
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

5.  Stimulators and inhibitors of hepatic porphyrin formation in human sera.

Authors:  A B Rifkind; S Sassa; I R Merkatz; R Winchester; L Harber; A Kappas
Journal:  J Clin Invest       Date:  1974-04       Impact factor: 14.808

6.  Studies in porphyria. IV. Expression of the gene defect of acute intermittent porphyria in cultured human skin fibroblasts and amniotic cells: prenatal diagnosis of the porphyric trait.

Authors:  S Sassa; G Solish; R D Levere; A Kappas
Journal:  J Exp Med       Date:  1975-09-01       Impact factor: 14.307

7.  Studies in porphyria. II. Evidence for a deficiency of steroid delta-4-5-alpha-reductase activity in acute intermittent porphyria.

Authors:  H L Bradlow; P N Gillette; T F Gallagher; A Kappas
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

8.  Adrenal hormonal imbalance in acute intermittent porphyria patients: results of a case control study.

Authors:  Oscar J Pozo; Josep Marcos; Andreu Fabregat; Rosa Ventura; Gregori Casals; Paula Aguilera; Jordi Segura; Jordi To-Figueras
Journal:  Orphanet J Rare Dis       Date:  2014-04-16       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.